Measure Description:
Among women ages 15 through 44 who had a live birth, the percentage that is provided:
1) A most effective (i.e., sterilization, implants, intrauterine devices or systems (IUD/IUS)) or moderately (i.e., injectables, oral pills, patch, ring, or diaphragm) effective method of contraception within 3 and 60 days of delivery.
2) A long-acting reversible method of contraception (LARC) within 3 and 60 days of delivery.
Two time periods are proposed (i.e., within 3 and within 60 days of delivery) because each reflects important clinical recommendations from the U.S. Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG). The 60-day period reflects ACOG recommendations that women should receive contraceptive care at the 6-week postpartum visit. The 3-day period reflects CDC and ACOG recommendations that the immediate postpartum period (i.e., at delivery, while the woman is in the hospital) is a safe time to provide contraception, which may offer greater convenience to the client and avoid missed opportunities to provide contraceptive care.
Numerator Statement:
Primary measure: Women ages 15 through 44 who had a live birth and were provided a most (sterilization, intrauterine device, implant) or moderately (pill, patch, ring, injectable, diaphragm) effective method of contraception within 3 and 60 days of delivery.
Sub-measure: Women ages 15 through 44 who had a live birth and were provided a long-acting reversible method of contraception (LARC) within 3 and 60 days of delivery.
Numerator Details:
${NumeratorDetails}
Denominator Statement:
Women ages 15 through 44 who had a live birth in a 12-month measurement year.
Denominator Details:
${DenominatorDetails}
Exclusions:
The following categories are excluded from the denominator: (1) deliveries that did not end in a live birth (i.e., miscarriage, ectopic, stillbirth or induced abortion); and (2) deliveries that occurred during the last two months of the measurement year.
Exclusion Details:
${DenominatorExclusionDetails}
Risk Adjustment:
No
Classification:
Measure Type:
Outcome: Intermediate Clinical Outcome
Measure Format:
measure
Use in Federal Program:
Condition:
Perinatal Health, Perinatal Health: Newborn Care
Non-Condition Specific:
Access to Care, Primary Prevention
Care Setting:
Other
National Quality Strategy Priorities:
Affordable Care: Access
Actual/Planned Use:
Data Source:
Claims
Level of Analysis:
Health Plan, Population: Regional and State
Target Population:
Children, Women
Measure Steward Contact Information:
For additional measure specification information, please contact the Measure Steward.
Organization Name:
US Office of Population Affairs
Email Address:
Website URL:
Measure Disclaimer:
Not applicable
Measure Steward Copyright:
Not applicable
34
6